Mycosis fungoides and Sézary syndrome: Clinical, immunological and molecular distinctions that suggest two different diseases

Xuesong Wu, Samuel T Hwang

Research output: Contribution to journalArticle

Abstract

Although mycosis fungoides and Sézary syndrome are presently defined by the WHO/European Organization for Research and Treatment of Cancer criteria as two distinct subtypes of cutaneous T-cell lymphoma, the two diseases present with some overlapping clinical and pathological features and share the same staging system. Advances in understanding the roles and immunologic features of different subsets of T helper cells have allowed researchers to segregate mycosis fungoides and Sézary syndrome with more precision, suggesting that these diseases, despite some similarities, arise from distinct T-cell subsets. New evidence acquired from recent studies in genetics and molecular signaling pathways has contributed to a more comprehensive understanding of these two disease entities, supporting this theory. The purpose here is to survey recent advances in the biological origin, immunophenotype, genetics and molecular profiles of mycosis fungoides and Sézary syndrome, leading to a greater understanding of the differences between the two entities that will allow for improved diagnosis, prognosis and treatment.

Original languageEnglish (US)
Pages (from-to)181-193
Number of pages13
JournalExpert Review of Dermatology
Volume7
Issue number2
DOIs
StatePublished - Apr 2012
Externally publishedYes

Fingerprint

Mycosis Fungoides
Molecular Biology
Cutaneous T-Cell Lymphoma
T-Lymphocyte Subsets
Helper-Inducer T-Lymphocytes
Research Personnel
Organizations
Therapeutics
Research
Neoplasms

Keywords

  • cutaneous T-cell lymphoma
  • distinction
  • immunophenotype
  • miRNA
  • mycosis fungoides
  • pathogenesis
  • Sézary syndrome
  • transcription factors

ASJC Scopus subject areas

  • Dermatology

Cite this

@article{81facbc1a68e4294b7ca16e0c5df0e44,
title = "Mycosis fungoides and S{\'e}zary syndrome: Clinical, immunological and molecular distinctions that suggest two different diseases",
abstract = "Although mycosis fungoides and S{\'e}zary syndrome are presently defined by the WHO/European Organization for Research and Treatment of Cancer criteria as two distinct subtypes of cutaneous T-cell lymphoma, the two diseases present with some overlapping clinical and pathological features and share the same staging system. Advances in understanding the roles and immunologic features of different subsets of T helper cells have allowed researchers to segregate mycosis fungoides and S{\'e}zary syndrome with more precision, suggesting that these diseases, despite some similarities, arise from distinct T-cell subsets. New evidence acquired from recent studies in genetics and molecular signaling pathways has contributed to a more comprehensive understanding of these two disease entities, supporting this theory. The purpose here is to survey recent advances in the biological origin, immunophenotype, genetics and molecular profiles of mycosis fungoides and S{\'e}zary syndrome, leading to a greater understanding of the differences between the two entities that will allow for improved diagnosis, prognosis and treatment.",
keywords = "cutaneous T-cell lymphoma, distinction, immunophenotype, miRNA, mycosis fungoides, pathogenesis, S{\'e}zary syndrome, transcription factors",
author = "Xuesong Wu and Hwang, {Samuel T}",
year = "2012",
month = "4",
doi = "10.1586/edm.12.7",
language = "English (US)",
volume = "7",
pages = "181--193",
journal = "Expert Review of Dermatology",
issn = "1746-9872",
publisher = "Expert Reviews Ltd.",
number = "2",

}

TY - JOUR

T1 - Mycosis fungoides and Sézary syndrome

T2 - Clinical, immunological and molecular distinctions that suggest two different diseases

AU - Wu, Xuesong

AU - Hwang, Samuel T

PY - 2012/4

Y1 - 2012/4

N2 - Although mycosis fungoides and Sézary syndrome are presently defined by the WHO/European Organization for Research and Treatment of Cancer criteria as two distinct subtypes of cutaneous T-cell lymphoma, the two diseases present with some overlapping clinical and pathological features and share the same staging system. Advances in understanding the roles and immunologic features of different subsets of T helper cells have allowed researchers to segregate mycosis fungoides and Sézary syndrome with more precision, suggesting that these diseases, despite some similarities, arise from distinct T-cell subsets. New evidence acquired from recent studies in genetics and molecular signaling pathways has contributed to a more comprehensive understanding of these two disease entities, supporting this theory. The purpose here is to survey recent advances in the biological origin, immunophenotype, genetics and molecular profiles of mycosis fungoides and Sézary syndrome, leading to a greater understanding of the differences between the two entities that will allow for improved diagnosis, prognosis and treatment.

AB - Although mycosis fungoides and Sézary syndrome are presently defined by the WHO/European Organization for Research and Treatment of Cancer criteria as two distinct subtypes of cutaneous T-cell lymphoma, the two diseases present with some overlapping clinical and pathological features and share the same staging system. Advances in understanding the roles and immunologic features of different subsets of T helper cells have allowed researchers to segregate mycosis fungoides and Sézary syndrome with more precision, suggesting that these diseases, despite some similarities, arise from distinct T-cell subsets. New evidence acquired from recent studies in genetics and molecular signaling pathways has contributed to a more comprehensive understanding of these two disease entities, supporting this theory. The purpose here is to survey recent advances in the biological origin, immunophenotype, genetics and molecular profiles of mycosis fungoides and Sézary syndrome, leading to a greater understanding of the differences between the two entities that will allow for improved diagnosis, prognosis and treatment.

KW - cutaneous T-cell lymphoma

KW - distinction

KW - immunophenotype

KW - miRNA

KW - mycosis fungoides

KW - pathogenesis

KW - Sézary syndrome

KW - transcription factors

UR - http://www.scopus.com/inward/record.url?scp=84859114063&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84859114063&partnerID=8YFLogxK

U2 - 10.1586/edm.12.7

DO - 10.1586/edm.12.7

M3 - Article

AN - SCOPUS:84859114063

VL - 7

SP - 181

EP - 193

JO - Expert Review of Dermatology

JF - Expert Review of Dermatology

SN - 1746-9872

IS - 2

ER -